CMS Issues Deficiency Letter to Theranos
Theranos is once again in the media spotlight due to negative attention it has received from a government regulatory agency. Last year, the U.S. Food and Drug Administration (FDA) released documents indicating its position that Theranos’ nanotainer used for collecting blood samples is a class II medical device and listing concerns about certain aspects of […]
This content is exclusive to Lab Compliance Advisor subscribers
Start a Free Trial for immediate access to this article and our entire archive of over 20 years of LCA reports.